Compare AWF & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AWF | ABCL |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 924.4M | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | AWF | ABCL |
|---|---|---|
| Price | $10.66 | $3.52 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | 190.0K | ★ 3.8M |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 7.57% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,325,000.00 |
| Revenue This Year | N/A | $25.45 |
| Revenue Next Year | N/A | $10.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.17 |
| 52 Week Low | $9.20 | $1.89 |
| 52 Week High | $10.67 | $6.52 |
| Indicator | AWF | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 37.56 |
| Support Level | $10.53 | $3.51 |
| Resistance Level | $10.86 | $3.86 |
| Average True Range (ATR) | 0.07 | 0.18 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 1.05 | 22.73 |
Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.